Vimarsana
Biggest News Aggregation in the World

Page 2 - Cangaroo Envelope News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cangaroo Envelope. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cangaroo Envelope Today - Breaking & Trending Today

Elutia (NASDAQ:ELUT) Now Covered by Analysts at Lake Street Capital - Vimarsana News

Elutia (NASDAQ:ELUT) Now Covered by Analysts at Lake Street Capital

Lake Street Capital began coverage on shares of Elutia (NASDAQ:ELUT – Free Report) in a research note released on Thursday morning, MarketBeat.com reports. The brokerage issued a buy rating on the stock. Separately, Cantor Fitzgerald reiterated an overweight rating and issued a $8.00 price target on shares of Elutia in a research note on Tuesday, […]

Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio Seite 1 - Vimarsana News

Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio Seite 1

20.04.2023 - SILVER SPRING, Md., April 20, 2023 (GLOBE NEWSWIRE) - Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, ... Seite 1

Aziyo Biologics Announces Closing of $14.0 Million Private - Vimarsana News

Aziyo Biologics Announces Closing of $14.0 Million Private

SILVER SPRING, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (the “Company”), a commercial-stage regenerative medicine company focused on...

Aziyo Biologics Announces Updated CanGaroo® Envelope Label in European Markets to Allow for Hydration in an Antibiotic Solution - Vimarsana News

Aziyo Biologics Announces Updated CanGaroo® Envelope Label in European Markets to Allow for Hydration in an Antibiotic Solution

Published: Jan 28, 2021 SILVER SPRING, Md., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced that it has received CE Mark approval for updated labeling of the Company’s biological CanGaroo® Envelope to allow for the addition of the antibiotic gentamicin. While the indications of the CanGaroo Envelope remain unchanged, this approval now permits the envelope to be hydrated in a gentamic...